We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$12.7M
2
RPAR icon
RPAR Risk Parity ETF
RPAR
+$5.28M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$4.15M
4
BAC icon
Bank of America
BAC
+$4.06M
5
NVDA icon
NVIDIA
NVDA
+$3.33M

Top Sells

Rank Stock Value
1
ORMP icon
Oramed Pharmaceuticals
ORMP
+$4.61M
2
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$4.54M
3
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$4.45M
4
IEO icon
iShares US Oil & Gas Exploration & Production ETF
IEO
+$4.15M
5
AGEN
Agenus
AGEN
+$2.89M

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLS icon
2101
Flowserve
FLS
$10.2B
$2.79K ﹤0.01%
82
– –
AVNS
2102
DELISTED
Avanos Medical
AVNS
$2.77K ﹤0.01%
93
-37
-28% -$1.07K
MEI icon
2103
Methode Electronics
MEI
$592M
$2.76K ﹤0.01%
63
– –
ST icon
2104
Sensata Technologies
ST
$6.79B
$2.75K ﹤0.01%
55
+8
+17% +$387
CERT icon
2105
Certara
CERT
$1.25B
$2.75K ﹤0.01%
114
– –
TARO
2106
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.75K ﹤0.01%
113
-130
-53% -$3.79K
TNC icon
2107
Tennant Co
TNC
$1.26B
$2.74K ﹤0.01%
40
– –
MTG icon
2108
MGIC Investment
MTG
$6.25B
$2.74K ﹤0.01%
204
– –
SPB icon
2109
Spectrum Brands
SPB
$2.07B
$2.71K ﹤0.01%
41
– –
NWL icon
2110
Newell Brands
NWL
$2.56B
$2.71K ﹤0.01%
218
-309
-59% -$4.36K
MGNX icon
2111
MacroGenics
MGNX
$257M
$2.71K ﹤0.01%
+378
New +$2.28K
THO icon
2112
Thor Industries
THO
$4.14B
$2.71K ﹤0.01%
34
-146
-81% -$12.9K
NPO icon
2113
Enpro
NPO
$7.05B
$2.7K ﹤0.01%
26
– –
NRIX icon
2114
Nurix Therapeutics
NRIX
$2.65B
$2.69K ﹤0.01%
303
+144
+91% +$1.5K
SHYF
2115
DELISTED
The Shyft Group
SHYF
$2.69K ﹤0.01%
118
+78
+195% +$2.19K
CLS icon
2116
Celestica
CLS
$36.5B
$2.68K ﹤0.01%
208
– –
WLK icon
2117
Westlake Corp
WLK
$9.9B
$2.67K ﹤0.01%
23
– –
BATRA icon
2118
Atlanta Braves Holdings Series A
BATRA
$3.43B
$2.66K ﹤0.01%
77
– –
TRIP icon
2119
TripAdvisor
TRIP
$1.26B
$2.66K ﹤0.01%
134
– –
MORN icon
2120
Morningstar
MORN
$7.53B
$2.64K ﹤0.01%
13
+9
+225% +$1.98K
PENG
2121
Penguin Solutions Inc
PENG
$2.99B
$2.64K ﹤0.01%
+153
New +$2.56K
MARA icon
2122
Marathon Digital Holdings
MARA
$3.9B
$2.63K ﹤0.01%
302
+208
+221% +$1.45K
LCTX icon
2123
Lineage Cell Therapeutics
LCTX
$278M
$2.63K ﹤0.01%
1,754
– –
AUB icon
2124
Atlantic Union Bankshares
AUB
$5.97B
$2.63K ﹤0.01%
75
– –
CSTM icon
2125
Constellium
CSTM
$3.99B
$2.63K ﹤0.01%
172
– –
83 84
85
86 87

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.